.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Cantor Fitzgerald
McKesson
Federal Trade Commission
Deloitte
Cipla
Citi
Dow
Julphar
Boehringer Ingelheim

Generated: July 25, 2017

DrugPatentWatch Database Preview

Xenon xe-133 - Generic Drug Details

« Back to Dashboard

What are the generic sources for xenon xe-133 and what is the scope of xenon xe-133 freedom to operate?

Xenon xe-133
is the generic ingredient in three branded drugs marketed by Mallinkrodt Nuclear, Gen Electric, Ge Healthcare, Mallinckrodt, and Lantheus Medcl, and is included in seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for xenon xe-133. Two suppliers are listed for this compound.

Summary for Generic Name: xenon xe-133

Tradenames:3
Patents:1
Applicants:5
NDAs:7
Drug Master File Entries: see list11
Suppliers / Packagers: see list2
Clinical Trials: see list120
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:xenon xe-133 at DailyMed

Pharmacology for Ingredient: xenon xe-133

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinkrodt Nuclear
XENON XE 133
xenon xe-133
GAS;INHALATION018327-002Mar 9, 1982RXNoNo► Subscribe► Subscribe► Subscribe
Lantheus Medcl
XENON XE 133
xenon xe-133
GAS;INHALATION017284-001Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe► Subscribe
Ge Healthcare
XENON XE 133
xenon xe-133
INJECTABLE;INJECTION017256-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mallinkrodt Nuclear
XENON XE 133
xenon xe-133
GAS;INHALATION018327-001Mar 9, 1982RXNoNo► Subscribe► Subscribe► Subscribe
Ge Healthcare
XENON XE 133
xenon xe-133
GAS;INHALATION017687-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Deloitte
Mallinckrodt
Harvard Business School
Fish and Richardson
Citi
Teva
Accenture
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot